United States Psoriasis Market: Valuations, Epidemiology, Drugs Sales & Shares, Competitive Landscape (2016-2025) - ResearchAndMarkets.com

DUBLIN--()--The "US Psoriasis Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

This report provides comprehensive insights into Psoriasis pipeline products, Psoriasis epidemiology, Psoriasis market valuations and forecast, Psoriasis drugs sales and competitive landscape in the US.

The report is classified into seven sections - Psoriasis treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

  • Psoriasis pipeline: Find out the products in clinical trials for the treatment of Psoriasis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Psoriasis epidemiology: Find out the number of patients diagnosed (prevalence) with Psoriasis in the US
  • Psoriasis drugs: Identify key products marketed and prescribed for Psoriasis in the US, including trade name, molecule name, and company
  • Psoriasis drugs sales: Find out the sales revenues of Psoriasis drugs in the US
  • Psoriasis market valuations: Find out the market size for Psoriasis drugs in 2019 in the US. Find out how the market advanced from 2016 and forecast to 2025
  • Psoriasis drugs market share: Find out the market shares for key Psoriasis drugs in the US

Benefits of this Research

  • Support monitoring and reporting national Psoriasis market analysis and sales trends
  • Track competitor drugs sales and market share in the US Psoriasis market
  • Track competitive developments in Psoriasis market and present key issues and learnings
  • Synthesize insights for Psoriasis market and products to drive business performance
  • Answer key business questions about the Psoriasis market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Psoriasis products
  • Supports decision making in R&D to long term marketing strategies

Key Topics Covered

1) Psoriasis Treatments

2) Psoriasis Pipeline

3) US Psoriasis Epidemiology

4) Marketed Drugs for Psoriasis in US

5) US Psoriasis Market Size and Forecast

6) US Psoriasis Products Sales and Forecast

7) US Psoriasis Market Competitive Landscape

8) Methodology

List of Tables

1. Psoriasis Phase 3 Clinical Trials, 2020

2. Psoriasis Phase 2 Clinical Trials, 2020

3. Psoriasis Phase 1 Clinical Trials, 2020

4. Psoriasis Epidemiology, US, 2016-2025

5. Marketed Drugs for Psoriasis, US, 2019

6. Psoriasis Market Size and Forecast ($), US, 2016-2025

7. Psoriasis Product Sales ($), US, 2016-2025

List of Figures

1. Psoriasis Epidemiology, US, 2016-2025

2. Psoriasis Market Size and Forecast ($), US, 2016-2025

3. Psoriasis Products Market Share (%), US, 2019

For more information about this report visit https://www.researchandmarkets.com/r/kbko30

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900